Back to Search Start Over

Surveillance Endoscopy in the Management of Hereditary Diffuse Gastric Cancer Syndrome.

Authors :
Friedman, Madeline
Adar, Tomer
Patel, Devanshi
Lauwers, Gregory Y.
Yoon, Sam S.
Mullen, John T.
Chung, Daniel C.
Source :
Clinical Gastroenterology & Hepatology; Jan2021, Vol. 19 Issue 1, p189-191, 3p
Publication Year :
2021

Abstract

Hereditary diffuse gastric cancer (HDGC) syndrome results from a germline CDH1 mutation, and microscopic foci of signet-ring carcinoma cells (SRCC) are present in nearly all gastrectomy specimens.<superscript>1</superscript> The lifetime risk of invasive gastric cancer (GC) has been thought to be 70%,<superscript>2</superscript> but recent data have suggested a lower risk of 37%.<superscript>3</superscript> Prophylactic total gastrectomy is considered the standard of care, but many patients choose surveillance endoscopy instead. We sought to define the outcomes in CDH1 -positive individuals who pursued endoscopic surveillance. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15423565
Volume :
19
Issue :
1
Database :
Supplemental Index
Journal :
Clinical Gastroenterology & Hepatology
Publication Type :
Academic Journal
Accession number :
147625134
Full Text :
https://doi.org/10.1016/j.cgh.2019.10.033